Prosecution Insights
Prosecution Insights
8 pending office actions • 4 art units • 6 examiners • 0 of 8 (0%) have an AI response strategy ready • 13 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (12%) |
| Double-patenting only | 2 (25%) |
| Double-patenting + other | 1 (12%) |
| Multi-statute (no §101) | 2 (25%) |
| No statute on record | 2 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KIM, YUNSOO | 3 | 65.8% | +34.8% |
| ROBINSON, HOPE A | 1 | 67.6% | +43.3% |
| CHERNYSHEV, OLGA N | 1 | 54.5% | +34.2% |
| NOLAN, JASON MICHAEL | 1 | 66.3% | -28.0% |
| FONTAINHAS, AURORA M | 1 | 38.0% | +49.1% |
| LEESER, ERICH A | 1 | 81.6% | +13.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17949188 | 1-[2-(2,4-DIMETHYLPHENYLSULFANYL)-PHENYL]PIPERAZINE AS A COMPOUND WITH COMBINED SEROTONIN REUPTAKE, 5-HT3 AND 5-HT1A ACTIVITY FOR THE TREATMENT OF COGNITIVE IMPAIRMENT | LEESER, ERICH A | 20d |
| 18534843 | ARGININE WASH IN PROTEIN PURIFICATION | ROBINSON, HOPE A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19070188 | COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SYSTEM ATROPHY (MSA) | KIM, YUNSOO | 22d overdue |
| 17949188 | 1-[2-(2,4-DIMETHYLPHENYLSULFANYL)-PHENYL]PIPERAZINE AS A COMPOUND WITH COMBINED SEROTONIN REUPTAKE, 5-HT3 AND 5-HT1A ACTIVITY FOR THE TREATMENT OF COGNITIVE IMPAIRMENT | LEESER, ERICH A | 20d |
| 17992403 | Agents, Uses and Methods for the Treatment of Synucleinopathy | FONTAINHAS, AURORA M | 22d |
| 19429170 | COMPOSITIONS AND METHODS FOR TREATING SYNUCLEINOPATHIES | KIM, YUNSOO | — |
| 19428909 | COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SYSTEM ATROPHY (MSA) | KIM, YUNSOO | — |
| 18534843 | ARGININE WASH IN PROTEIN PURIFICATION | ROBINSON, HOPE A | — |
| 18511241 | TREATMENT OF MEDICATION OVERUSE HEADACHE USING ANTI-CGRP OR ANTI-CGRP-R ANTIBODIES | CHERNYSHEV, OLGA N | — |
| Art Unit | Apps |
|---|---|
| 1641 | 3 |
| 1675 | 2 |
| 1623 | 1 |
| 1622 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19429170 | COMPOSITIONS AND METHODS FOR TREATING SYNUCLEINOPATHIES | KIM, YUNSOO | 1641 | DP | Final Rejection | — | Pending | Dec 22, 2025 |
| 19428909 | COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SYSTEM ATROPHY (MSA) | KIM, YUNSOO | 1641 | DP | Final Rejection | — | Pending | Dec 22, 2025 |
| 19070188 | COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SYSTEM ATROPHY (MSA) | KIM, YUNSOO | 1641 | §103DP | Final Rejection | 22d overdue | Pending | Mar 04, 2025 |
| 18534843 | ARGININE WASH IN PROTEIN PURIFICATION | ROBINSON, HOPE A | — | §103§112 | Non-Final OA | — | Pending | Dec 11, 2023 |
| 18511241 | TREATMENT OF MEDICATION OVERUSE HEADACHE USING ANTI-CGRP OR ANTI-CGRP-R ANTIBODIES | CHERNYSHEV, OLGA N | 1675 | Other | Final Rejection | — | Pending | Nov 16, 2023 |
| 18252611 | MAGL INHIBITORS | NOLAN, JASON MICHAEL | 1623 | Other | Final Rejection | — | Pending | May 11, 2023 |
| 17992403 | Agents, Uses and Methods for the Treatment of Synucleinopathy | FONTAINHAS, AURORA M | 1675 | §103Other | Final Rejection | 22d | Pending | Nov 22, 2022 |
| 17949188 | 1-[2-(2,4-DIMETHYLPHENYLSULFANYL)-PHENYL]PIPERAZINE AS A COMPOUND WITH COMBINED SEROTONIN REUPTAKE, 5-HT3 AND 5-HT1A ACTIVITY FOR THE TREATMENT OF COGNITIVE IMPAIRMENT | LEESER, ERICH A | 1622 | §103§112Other | Non-Final OA | 20d | Pending | Sep 20, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial